The device provides a stable environment for pacemaker pulse generator or defibrillator to hold itself securely upon implantation into the body of the patient and gets fully absorbed by the body approximately nine weeks after implantation. The envelope has a shelf life of about one year.
Speaking on the introduction of TYRX, Chairman and Head of Cardiology, Dr Balbir Singh said, “Many medical efforts, including various forms of advanced treatment, such as use of antibiotics have not been able to reduce the rate of such infections leading to a lot of pain and suffering in patients. In this latest technology, the pacemaker is placed in the TYRX pocket and then implanted. It contains the antimicrobial agents minocycline and rifampin, which help reduce infections of bacterial challenge following surgical implantation of the generator or defibrillator and is locally delivered, sustained for 7 days.”